Cochleovestibular involvement in patients with Fabry disease: data from the multicenter cohort FFABRY
暂无分享,去创建一个
D. Lacombe | A. Masseau | C. Lavigne | M. Willems | C. Durant | G. Michel | W. Mauhin | O. Lidove | H. Maillard | A. Gendre | Antoine Asquier-Khati | A. Asquier-Khati
[1] L. Køber,et al. Significant hearing loss in Fabry disease: Study of the Danish nationwide cohort prior to treatment , 2019, PloS one.
[2] T. Ohashi. [Current status and future prospect of enzyme replacement therapy for Fabry disease]. , 2019, Rinsho shinkeigaku = Clinical neurology.
[3] J. Moon,et al. Ventricular arrhythmia and sudden cardiac death in Fabry disease: a systematic review of risk factors in clinical practice , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[4] C. Wanner,et al. Characterization of vertigo and hearing loss in patients with Fabry disease , 2018, Orphanet Journal of Rare Diseases.
[5] N. Sousa,et al. Inner ear involvement in Fabry disease: Clinical and audiometric evaluation of a large cohort of patients followed in a reference centre. , 2018, European journal of medical genetics.
[6] C. Eng,et al. Fabry disease revisited: Management and treatment recommendations for adult patients. , 2018, Molecular genetics and metabolism.
[7] C. Wanner,et al. Cardiac and renal dysfunction is associated with progressive hearing loss in patients with Fabry disease , 2017, PloS one.
[8] R. Reisin,et al. Neuro-Otological and Peripheral Nerve Involvement in Fabry Disease , 2017, Audiology research.
[9] C. Wanner,et al. Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study. , 2017, Journal of the American Society of Nephrology : JASN.
[10] D. Lockhart,et al. The validation of pharmacogenetics for the identification of Fabry patients to be treated with migalastat , 2016, Genetics in Medicine.
[11] G. Andria,et al. Pharmacological Chaperone Therapy: Preclinical Development, Clinical Translation, and Prospects for the Treatment of Lysosomal Storage Disorders. , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.
[12] Richard B. Thompson,et al. Anderson-Fabry cardiomyopathy: prevalence, pathophysiology, diagnosis and treatment , 2015, Heart Failure Reviews.
[13] W. Dreschler,et al. Hearing loss in adult patients with Fabry disease treated with enzyme replacement therapy , 2015, Journal of Inherited Metabolic Disease.
[14] J. England,et al. Fabry's disease , 2014, Journal of the Neurological Sciences.
[15] Luigi Ferrucci,et al. Hearing loss prevalence in the United States. , 2011, Archives of internal medicine.
[16] P. Herman,et al. Atteintes ORL de la maladie de Fabry : à propos de 25 observations , 2011 .
[17] G. Gates,et al. Challenges and Opportunities in Presbycusis , 2010, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[18] C. Eng,et al. Characterization of Fabry Disease in 352 Pediatric Patients in the Fabry Registry , 2008, Pediatric Research.
[19] D. Straumann,et al. Vestibular and auditory deficits in Fabry disease and their response to enzyme replacement therapy , 2007, Journal of Neurology.
[20] J M Dambrosia,et al. Neuropathic and cerebrovascular correlates of hearing loss in Fabry disease. , 2006, Brain : a journal of neurology.
[21] S. Brodie,et al. Fabry disease: Guidelines for the evaluation and management of multi-organ system involvement , 2006, Genetics in Medicine.
[22] P. Avan,et al. La maladie de Fabry : l'atteinte vasculaire multi-organe pourrait également intéresser la cochlée , 2006 .
[23] A. Roscher,et al. Disease manifestations and X inactivation in heterozygous females with Fabry disease , 2006, Acta paediatrica (Oslo, Norway : 1992). Supplement.
[24] P. Avan,et al. Patients affected with Fabry disease have an increased incidence of progressive hearing loss and sudden deafness: an investigation of twenty-two hemizygous male patients , 2002, BMC Medical Genetics.
[25] R B D'Agostino,et al. Central auditory dysfunction, cognitive dysfunction, and dementia in older people. , 1996, Archives of otolaryngology--head & neck surgery.